Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer
Authors
Keywords
Ovarian cancer, DNA methylation, MicroRNAs, Metastasis, Tumor suppressor genes, Cancer detection and diagnosis, Lymph nodes, Polymerase chain reaction
Journal
PLoS One
Volume 11, Issue 4, Pages e0153902
Publisher
Public Library of Science (PLoS)
Online
2016-04-20
DOI
10.1371/journal.pone.0153902
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b
- (2015) Shuang Luo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients
- (2015) M Wang et al. BRITISH JOURNAL OF CANCER
- Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
- (2015) A. Yamada et al. CLINICAL CANCER RESEARCH
- MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4
- (2015) Jun-Nian Zhou et al. HEPATOLOGY
- The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα
- (2015) P Vargas Romero et al. LEUKEMIA
- The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer
- (2015) Xiaohong Xie et al. TUMOR BIOLOGY
- MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
- (2015) Qingling Yang et al. Oncotarget
- miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development
- (2015) Joana Ribeiro et al. Biomed Research International
- Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis
- (2015) William T. Budd et al. PLoS One
- Good guy or bad guy: the opposing roles of microRNA 125b in cancer
- (2014) Julia Banzhaf-Strathmann et al. Cell Communication and Signaling
- Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research
- (2014) Angiolo Gadducci et al. GYNECOLOGICAL ENDOCRINOLOGY
- Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma
- (2014) Burcu Gurer Giray et al. MOLECULAR BIOLOGY REPORTS
- MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases
- (2013) Joana Heinzelmann et al. ANNALS OF SURGICAL ONCOLOGY
- MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
- (2013) N Wu et al. BRITISH JOURNAL OF CANCER
- Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis
- (2013) Jun He et al. PLoS One
- Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis
- (2012) Ma Yuxia et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- DNA methylation and microRNA dysregulation in cancer
- (2012) Hiromu Suzuki et al. Molecular Oncology
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo
- (2011) Feizhou Jiang et al. BMC CANCER
- MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
- (2011) N. Nishida et al. CLINICAL CANCER RESEARCH
- Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome
- (2011) Rocio G. Urdinguio et al. Epigenetics
- MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
- (2011) James W.F. Catto et al. EUROPEAN UROLOGY
- miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
- (2011) Fanfei Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- MiR-125b targets BCL3 and suppresses ovarian cancer proliferation
- (2010) Yi Guan et al. INTERNATIONAL JOURNAL OF CANCER
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
- (2010) Laura Poliseno et al. NATURE
- Subtle variations in Pten dose determine cancer susceptibility
- (2010) Andrea Alimonti et al. NATURE GENETICS
- The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
- (2009) J. T. Huse et al. GENES & DEVELOPMENT
- TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
- (2009) Mitsuo Kato et al. NATURE CELL BIOLOGY
- Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells
- (2008) Shu Takakura et al. CANCER SCIENCE
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer
- (2008) Robyn L. Prueitt et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started